Powered by: Motilal Oswal
2025-12-17 11:24:43 am | Source: Accord Fintech
Nephrocare Health Services lists at 7% premium on the BSE
Nephrocare Health Services lists at 7% premium on the BSE

Nephrocare Health Services has debuted at Rs 491.70 on the BSE, up by 31.7 points or 6.89% from its issue price of Rs 460.00.

The scrip is currently trading at Rs. 478.00, up by 18 points or 3.91% from its issue price.

It has touched a high and low of Rs. 498.70 and Rs. 475.95 respectively. So far 14.00 lakh shares were traded on the counter.

The offering, which was open for subscription between December 10, 2025 and December 12, 2025 was subscribed 14.08 times. The issue price was fixed at Rs 460.00 per share i.e. at upper end of price band of Rs 438-460 apiece.

Nephrocare Health Services offers comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here